The AHSN are proud to be hosting the Innovation Zone at the 2021 NHS Virtual Confed Conference, taking place between 15 and 17 June.
Come and hear from AHSN representatives from across the Network at a number of content sessions; or visit our virtual stand to discover the impact AHSNs have had over the past year.
As well as our own sessions, the AHSN Network’s Innovation Zone will also be hosting talks from the Accelerated Access Collaborative (AAC) and the NHS Innovation Accelerator (NIA).
The following sessions are scheduled to take place:
10:30-11am – Enabling NHS Artificial Intelligence Solutions
Led by Daniel Bamford, Deputy Director AI Award, Accelerated Access
Led by Richard Stubbs, Chief Executive, Yorkshire and Humber AHSN and AHSN Network Vice Chair, with Suzanne Ali-Hassan, Commercial Engagement Lead, UCLPartners
2:30-3pm – How do AHSNs spread innovation?
Led by Professor Gary Ford, Chief Executive Officer, Oxford AHSN and AHSN Network Chair
Dr Andrew Sibley, Evaluation Programme Manager, Wessex AHSN
Sarah Robens, Evaluation Lead and Spread Fellow, South West AHSN
Dr Alexandra Ziemann, Senior Research Fellow, Centre for Healthcare Innovation Research, City, University of London
Led by Richard Stubbs, Chief Executive, Yorkshire and Humber AHSN and AHSN Network Vice Chair
Michael Goodeve, Associate Director of Communications, Wessex AHSN
Vanesther Hamer, Head of Communications, West of England AHSN
Laurence Webb, Deputy Director of Inclusion, LGBT Foundation,
Phillipa James, GP, Indigo Gender Service
Meg lightheart, Service Manager, Indigo Gender Service
Led by Dr Amanda Begley, NHS Innovation Accelerator National Director, Director of Innovation and Implementation for UCLPartners
Dr Bola Owolabi, Director of Health Inequalities at NHS England & NHS Improvement
Representative from NICE
Deborah O’Callaghan, Associate Director Midlands and East, NICE
Led by Mike Roberts, Managing Director, UCLPartners
Usha Boolaky, Assistant Director for Research, Health Foundation
Dr Manbinder Sidhu, BRACE Research Fellow, University of Birmingham
Dara Coppel, Head of Innovation Programme Delivery, East Midlands AHSN and AHSN Network National Focus ADHD Programme Lead
Amy Semple, National Programme Manager Early Intervention Eating Disorders, Health Innovation Network
Danielle Glennon, Clinical Lead and FREED National Co Lead, South London and Maudsley NHS Trust
Mark Dines-Allen, National Programme Manager, Focus ADHD
Led by Dr Matt Kearney, Programme Director for CVD Prevention and Proactive Care, UCLPartners
Gemma Summerson, Senior Innovation Lead – Innovation Programme Delivery, East Midlands AHSN
Tim Straughan, Director of NHS @Home, NHS England & NHS Improvement
Led by Professor Julia Newton, Medical Director, AHSN North East North Cumbria (NENC)
Professor Nicholas J Linker BSc MD FRCP ECDS FACC FESC FHRS, National Clinical Director for Heart Disease, NHS England & NHS Improvement and Consultant Cardiologist
Dr Dermot Neely, Strategic Clinical Advisor, AAC/AHSN Lipid Management and Familial Hypercholesterolaemia Programme
Led by Cheryl Crocker, Patient Safety Director, AHSN Network
Matt Inada-Kim, National Clinical Director, Deterioration and Sepsis, and Covid Oximetry @home lead, NHS England/Improvement
Paul Durrands, Chief Operating Officer, Oxford AHSN
Led by Maria Kyriacou, Interim Deputy Director, NHS Innovation Accelerator
Anastasiia Kucherenko - VineHealth
Arjun Panesar - Diabetes Digital Media
Emilio Sanz-Pereiras - NIA Fellow
Keren Miller - Oviva
Mark Jenkins - Oviva (NIA Alumni)
For full details on these sessions and how to join, visit the NHS Virtual Confed Conference website.
As well as our own sessions, a number of AHSN representatives will also be joining other sessions on the agenda, including Matt Kearney from UCLPartners and Julia Newton, from AHSN NENC, speaking about ‘Tackling CVD and health care inequalities through population health management’; and Mike Roberts from UCLPartners speaking on ‘evaluating the beneficial changes from the pandemic response’. Richard Stubbs will also be joining a panel in the International Zone, to discuss ‘the benefits of global innovation: improving service delivery and patient outcomes’.